17.31USD+0.46%Mkt Cap: 5.52B $P/E: 46.781d ago
Amneal Pharmaceuticals, Inc., a global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products in the United States, I…
Industry Peers
Drug Manufacturers - Specialty & Genericvs Drug Manufacturers - Specialty & Generic
P/E
Pricier
1M Perf
Lower
$69.40BUSDP/E 25.2
$23.00BUSDP/E 20.0
$18.49BUSD
$16.95BUSDP/E 26.0
$15.35BUSDP/E 175.0
$15.16BUSDP/E 31.8
$12.29BUSD
$8.30BUSDP/E 21.1
$8.02BUSD
$7.22BUSDP/E 26.5
$7.09BUSDP/E 469.0
$3.54BUSDP/E 18.4
$3.48BUSDP/E 11.1
$3.22BUSDP/E 22.4
$2.66BUSDP/E 59.3
$2.70BUSD
$2.54BUSDP/E 17.6
$2.54BUSD
$2.24BUSDP/E 12.1
$1.92BUSDP/E 19.4
$2.00BUSD
$1.77BUSD
$1.88BUSDP/E 21.2
$1.90BUSD
$1.56BUSDP/E 18.4
$1.58BUSD
$1.37BUSDP/E 113.1
$1.27BUSDP/E 13.5
$1.13BUSDP/E 35.6
$1.17BUSDP/E 17.6
$1.23BUSD
$1.09BUSD
$1.07BUSDP/E Infinity
$964.80MUSD
$998.26MUSDP/E 195.2
$991.60MUSD
$912.76MUSDP/E 39.9
$895.85MUSDP/E 14.4
$889.80MUSDP/E 12.2
$814.31MUSDP/E Infinity
$693.02MUSDP/E 6.8
$704.28MUSDP/E 164.2
$522.76MUSDP/E 14.7
$521.87MUSD
$488.71MUSD
$457.03MUSD
$450.66MUSD
$432.38MUSD
$323.33MUSD
$317.55MUSDP/E 43.3
$312.68MUSD
$342.71MUSD
$305.81MUSD
$304.53MUSD
$288.10MUSDP/E 51.7
$308.25MUSDP/E 9.9
$294.94MUSDP/E 15.2
$268.98MUSDP/E 9.7
$250.67MUSDP/E 47.7
$261.08MUSDP/E 13.0
$239.98MUSDP/E 53.8
$196.92MUSD
$194.94MUSD
$194.66MUSD
$182.70MUSDP/E 8.8
$178.18MUSD
$147.49MUSDP/E 18.8
$151.86MUSD
$138.58MUSD
$148.14MUSD
$125.08MUSD
$119.66MUSDP/E 18.6
$100.44MUSD
$97.09MUSD
$85.39MUSDP/E 12.3
$80.64MUSD
$72.08MUSD
$66.94MUSDP/E 56.4
$67.12MUSD
$64.16MUSD
$66.36MUSDP/E 22.8
$55.72MUSD
$60.45MUSD
$48.97MUSD
$53.46MUSD
$50.41MUSD
$42.17MUSD
$43.54MUSD
$35.03MUSDP/E Infinity
$32.51MUSD
$29.51MUSD
$25.58MUSDP/E 221.0
$23.08MUSD
$23.13MUSD
$21.73MUSD
$21.66MUSD
$18.56MUSD
$16.34MUSD
$14.36MUSDP/E 17.5
$13.58MUSD
$12.11MUSD
$11.27MUSD
$11.45MUSD
$9.80MUSD
$8.90MUSD
$7.07MUSDP/E 0.3
$6.32MUSD
$5.89MUSD
$4.95MUSDP/E 4.0
$5.64MUSDP/E Infinity
$3.29MUSDP/E 1.4
$2.15MUSD
$1.93MUSD
$1.90MUSDP/E 32.5
$1.54MUSD
$668.8KUSD
$216.1KUSDP/E 0.0
$350USD
Indicators:|
Key Statistics
Company
Market Cap5.52B $
Enterprise Value8.10B $
Revenue (TTM)3.05B $
Gross Profit1.11B $
Net Income (TTM)72.06M $
Revenue/Share9.681 USD
Last Price17.31 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees8.7K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS03168L1052
Valuation
P/E (Trailing)46.78
P/E (Forward)15.41
PEG—
EV/EBITDA12.13
EV/Revenue2.66
P/S1.81
P/B-121.90
EPS (TTM)0.37
EPS (Forward)1.12
52W Range
7.66595% of range17.86
52W High17.86 USD
52W Low7.665 USD
Profitability
Gross Margin36.88%
Oper. Margin19.57%
EBITDA Margin21.92%
Profit Margin2.39%
ROE-101.78%
ROA1.96%
Growth
Revenue Growth3.90%
Earnings Growth384.60%
Cash Flow & Leverage
Operating CF339.99M $
CapEx (TTM)114.36M $
FCF Margin3.33%
FCF Yield1.84%
Net Debt2.50B $
Net Debt/EBITDA3.74
Balance Sheet
Debt/Equity-37.98
Current Ratio2.47
Quick Ratio1.51
Book Value/Sh-0.1420 USD
Cash/Share0.6290 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)17.25 USD
Upside (mean)-0.3%
Target Range16.00 USD – 19.00 USD
$16.00-0.3% to mean$19.00
# Analysts4
Ownership
Shares Out.319.33M
Float178.41M
Insiders44.12%
Institutions52.18%
Short Interest
Short Ratio4.3d
Short % Float3.82%
Short % Out.2.48%
Shares Short7.92M
Short (prev mo.)7.96M
Technical
SMA 5013.85 (+25.0%)
SMA 20012.61 (+37.3%)
Beta1.32
S&P 52W Chg20.05%
Avg Vol (30d)1.74M
Avg Vol (10d)2.75M
Technical Indicators
RSI (14)81.1
MACD1.0959
MACD Signal0.9637
MACD Hist.+0.1322
BB Upper18.70 USD
BB Middle15.44 USD
BB Lower12.18 USD
BB Width42.24%
ATR (14)0.5501 USD
Vol Ratio (20d)1.08x